Poster

Comparative Efficacy Of Consolidation Therapy After Chemoradiation Therapy (Crt) In Patients With Unresectable, Stage Iii Non-Small Cell Lung Cancer (Nsclc): A Network Meta-Analysis

Posted on

AUTHORS: Husain F., Harari O., Fazeli M., Zhang Y. CONFERENCE: ISPOR 2018 DATE: May 19-23, 2018. Objectives: This study aims to estimate the comparative clinical efficacy of consolidation therapies after cCRT, by using network meta-analysis (NMA). This current analysis focuses on progression free survival (PFS). See poster 2018-ISPOR-AstraZeneca-Poster

Poster

Transparency Matters: Use of Digital Software Platform in Replicating Published Systematic Literature Reviews and Network Meta-Analyses.

Posted on

AUTHORS: Husain, F., Kuang, Y., Feinman, T., Whittington, C., Sayre, T., del Aguila, M. CONFERENCE: ISPOR 2017 DATE: November 4-8, 2017 Objective(s): This work assessed the transparency and replicability of manual methods with comparison to software-assisted replication for search and analysis of published systematic literature reviews (SLRs) and network meta-analyses (NMAs). See poster 2017-ISPOR-DRE-Poster

Poster

Network meta-analysis of iGlarLixi, a fixed-ratio combination GLP-1 RA and basal insulin, versus insulin premix

Posted on

AUTHORS: Sayre T., Shah R., Thomas J., Murray E., Brulle-Wohlhueter C., Shaunik A., Perfetti R. CONFERENCE: IDF Congress 2017 DATE: December 4-8, 2017. Aim: To better understand the clinical efficacy of iGlarLixi compared with insulin intensification options, especially premix insulins, in patients with T2D inadequately controlled on BI See poster

Poster

Network meta-analysis of treatments for type 2 diabetes in patients inadequately controlled on oral antidiabetics

Posted on

AUTHORS: Shah R., Sayre T., Thomas J., Murray E., Brulle-Wohlhueter C., Shaunik A. CONFERENCE: IDF Congress 2017 DATE: December 4-8, 2017. Aim: To better understand the treatment efficacy and safety of fixed-ratio combinations (FRCs) of BI and GLP- 1 RA compared with BI, GLP- 1 RA or OAD monotherapy using network meta-analysis in the absence of head-to-head randomized controlled trials (RCT) See […]

Poster

Efficacy and safety of fixed-ratio combination of GLP-1 RA plus BI in type 2 diabetes mellitus: a network meta-analysis

Posted on

AUTHORS: Shah R., Sayre T., Thomas J., Murray E., Brulle-Wohlhueter C., Shaunik A. CONFERENCE: IDF Congress 2017 DATE: December 4-8, 2017. Aim: This review aimed to better understand the safety and efficacy of FRCs of GLP-1 RAs and basal insulin (BI) in comparison with BI, GLP-1 RA, basal-bolus insulin, premix insulin, and free combination GLP-1 RA and BI via […]

Poster

Term Indexing Technology to Support the Feasibility Assessment of a Benefit-Risk Network Meta-Analysis.

Posted on

AUTHORS: Snyder S., Bhattacharya M., Hendrickson B, Butylkova K, Lievano F; Scarzzini L, CONFERENCE: DIA Annual Meeting 2017 DATE: June 18-22, 2017. Objective: Perform a BRA of interventions across two therapeutic classes using a NMA approach Use term-indexing technology to improve synonym management, feasibility assessment, and outcome selection for NMA 2017-DIA-DRE-Abbvie-NMA-Poster See poster